No Data
No Data
Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy?
Express News | CNBC Halftime Report Final Trades: NVIDIA, AbbVie, Vertex Pharmaceuticals, ConocoPhillips
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor Drug Pipeline Market 2024 Featuring Vanda Pharmaceuticals, Novartis, Vernalis, Levolta Pharmaceuticals, & Vertex Pharmaceuticals
Vertex Pharmaceuticals Says Gene-Editing Therapy Demonstrates Clinical Benefits in Genetic Disease Trials
Vertex Pharmaceuticals (VRTX) said Friday its Casgevy gene-editing therapy demonstrated clinical benefits in trials in sickle cell disease and transfusion-dependent beta thalassemia. In sickle cell di
Express News | Vertex Reveals Long-Term Data On CASGEVY (Exagamglogene Autotemcel) At EHA 2024 Congress
Barclays Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $472
Barclays analyst Gena Wang maintains $Vertex Pharmaceuticals(VRTX.US)$ with a buy rating, and maintains the target price at $472.According to TipRanks data, the analyst has a success rate of 45.3% and